Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)
The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
marsuculix
(< 20)
Submitted: 5/23/2013 7:17:04 AM :
Start Price:
$17.96
ARIA Score:
+7.66
ASCO 2013 gives upside potential !
Recs
acekeldog
(34.37)
Submitted: 4/16/2013 1:13:39 PM :
Start Price:
$17.77
ARIA Score:
+4.05
Hoping the smart guys I follow are right.
Recs
zzlangerhans
(99.79)
Submitted: 3/28/2013 5:13:33 PM :
Start Price:
$18.35
ARIA Score:
-0.32
I'm not a fan of buying a stock going into a drug launch. That's typically a time when stocks are more likely to go down than up, and Ariad has proven to be no exception. The share price has declined twice since the approval of Iclusig in Decmber, once immediately after approval due to concerns about adverse effects on the label and once this week due to concerns about early prescription numbers. Iclusig's indication is limited to second line therapy in CML and the size of that market is debatable, so there is definitely reason to be nervous about weak numbers. The share price recently dipped below 18 from a high of 24 after approval and a recent peak of 22.
On the other hand, the share price seems to have stabilized, at least for the moment. Phase III trials of Iclusig in newly-diagnosed CML and as a therapy switch are in progress or on the launching pad, and Iclusig is likely to receive a favorable recommendation from CHMP in Q3 2013. Some smart people I follow on Twitter are moving back into the stock, not the least of whom is Portefeuille with whom I have a collaboration. So today I bought 200 shares at 18.2 for the collaboration account. So far, everything we've bought together has been a winner.
Recs
racosta52
(< 20)
Submitted: 3/6/2013 8:57:43 PM :
Start Price:
$21.17
ARIA Score:
-15.03
FDA approval of Iclusig; many positive estimates from number of analys.
Recs
ayuddha
(< 20)
Submitted: 7/15/2012 5:18:50 PM :
Start Price:
$17.39
ARIA Score:
-10.37
It was picked by www.hechtsoft.de Trade Alerts.
Recs
akbm7195
(60.88)
Submitted: 7/14/2012 1:11:40 PM :
Start Price:
$17.39
ARIA Score:
-10.37
Building a huge oncology group of medicines.
Recs
benyboy
(< 20)
Submitted: 6/29/2012 5:23:07 AM :
Start Price:
$17.23
ARIA Score:
-9.55
jim cramer buy buy buy
Recs
PDTBiotech
(94.51)
Submitted: 3/21/2012 11:54:03 AM :
Start Price:
$15.80
ARIA Score:
-5.05
Very rich valuation + unimpressive pipeline + stock went up (???) following 13-1 thrashing of ridaforolimus as maintenance therapy for patients with mSTS by ODAC.
Recs
portefeuille
(99.78)
Submitted: 12/15/2011 9:33:52 PM :
Start Price:
$11.76
ARIA Score:
+38.62
There are currently 400 ARIA shares in my "fund" with break-even of around -47.31 USD.
http://caps.fool.com/Blogs/fund-trades/678775.
Recs
KurtEng
(32.97)
Submitted: 8/17/2011 4:27:00 PM :
Start Price:
$9.13
ARIA Score:
-70.91
It could be a winner, but it is a LONG shot. I would rather bet on 6 red.
Recs
Allstar13913
(99.80)
Submitted: 7/30/2011 8:01:17 PM :
Start Price:
$9.21
ARIA Score:
-66.40
Another overvalued Biotech company. This company has never been profitable and seems to make all its money off partnerships.
http://www.fool.com/investing/general/2011/06/10/3-stocks-near-52-week-highs-worth-selling.aspx
Recs
polterziets
(< 20)
Submitted: 6/4/2011 5:51:01 PM :
Start Price:
$7.90
ARIA Score:
+118.69
growth and very undervalued
Recs
phatchips767
(< 20)
Submitted: 5/21/2011 2:06:32 PM :
Start Price:
$8.59
ARIA Score:
+100.95
pe of 14. One of the big monkees i watch likes it.
Recs
edizzo1
(< 20)
Submitted: 5/16/2011 12:17:14 AM :
Start Price:
$9.13
ARIA Score:
+89.05
Right now ARIA has everything going for it to see some big profits. I think it is a buy and I think we will see $20.00 a shear this year.
Ed Izzo
Recs
jcam180
(26.75)
Submitted: 5/12/2011 8:29:02 PM :
Start Price:
$9.24
ARIA Score:
+87.97
little money big upside, good products in pipeline
Recs
RazorSphinx
(< 20)
Submitted: 4/28/2011 7:31:45 AM :
Start Price:
$8.30
ARIA Score:
+112.05
Magic Formula
Recs
calor
(< 20)
Submitted: 4/6/2011 1:17:57 AM :
Start Price:
$8.48
ARIA Score:
+105.66
I have followed ARIA during 8 years, the research and technology in progress is very sophisticated, it will treat tumors that currently have no therapies and very poor prognosis. It will eventually take over by MERCK(MRK) which currently has a deal in one of the leading drugs to co-promote. Annual projected income in just this product is upwards of 1 Billion, profits to be shared. More to come from this great biotech company
Recs
syazic
(75.31)
Submitted: 3/28/2011 4:56:52 PM :
Start Price:
$7.27
ARIA Score:
+140.98
UPWARD trend is set.
Recs
joshcollis
(< 20)
Submitted: 3/8/2011 5:21:46 PM :
Start Price:
$6.01
ARIA Score:
+198.42
Solid management team and interesting products
Recs
reachmygoals1
(< 20)
Submitted: 2/1/2011 1:07:15 AM :
Start Price:
$6.42
ARIA Score:
+175.00
phase 3 sarcoma was successful. eun yang of jefferies and company have current price target at $11.00 next year will be huge.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 55 : 1 2 3 Next »